Neurones S.A (NRO) | Stock Overview & Key Data
Neurones S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €52.00 on March 3, 2025
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2024
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Neurones S.A
NRO
|
891.41M Mid-cap | -7.82% | -7.10% | 3.06% | -19.84% | -15.83% | -23.92% | -14.84% | 23.43% | 81.96% | 322.75% | 322.75% |
|
Capgemini SE
CAP
|
16.56B Large-cap | -5.80% | -3.54% | -8.18% | -35.13% | -31.47% | -35.69% | -45.92% | -38.22% | 11.53% | 240.56% | 240.56% |
|
Sopra Steria
SOP
|
2.34B Large-cap | -4.13% | 9.27% | 17.62% | -4.76% | -3.05% | -26.21% | -21.13% | -6.74% | 31.87% | 253.49% | 253.49% |
|
Atos SE
ATO
|
683.13M Mid-cap | -1.15% | -4.43% | -8.76% | -34.07% | -30.49% | -6.04% | -96.61% | -99.12% | -99.21% | -98.33% | -98.80% |
|
Aubay Société
AUB
|
559.86M Mid-cap | 0.70% | 11.72% | 37.83% | 3.25% | 2.14% | 14.75% | 19.96% | 28.07% | 181.19% | 761.91% | 788.89% |
|
Infotel
INF
|
254.43M Mid-cap | -1.43% | -5.35% | 4.68% | -12.84% | -9.52% | -1.27% | -29.01% | -23.58% | 20.32% | 242.73% | 242.73% |
Ownership & Short Interest
Calculate Your Neurones S.A Investment Returns
Long-Term Investment Performance Analysis
Neurones S.A stock price in Jul 2016 was €19.85, A €1,000.00 lump sum investment in Neurones S.A made 9 years ago would be worth approximately €1,780.86 today, representing a solid return of 78.09%. This translates to an annualized return (CAGR) of 6.00%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is NRO's 52-week high and low?
- In the last 52 weeks, Neurones S.A reached a high of €48.00 (on June 17, 2025) and a low of €31.90 (on March 24, 2026).
- What is the market cap and P/E ratio for NRO?
- Curious about Neurones S.A's size and valuation? Its market capitalization stands at 891.41M. When it comes to valuation, the P/E ratio (trailing twelve months) is 17.76, and the forward P/E (looking ahead) is 17.27.
- Does NRO pay dividends? If so, what's the yield?
- Yes, Neurones S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.76%, and the company has paid an average of €1.20 per share annually over the past 3 years.
- Who are Neurones S.A's main competitors or similar companies to consider before investing?
When looking at Neurones S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Capgemini SE
CAP16.56B Technology Information Technology Services -35.69% -45.92% Sopra Steria
SOP2.34B Technology Information Technology Services -26.21% -21.13% Atos SE
ATO683.13M Technology Information Technology Services -6.04% -96.61% Aubay Société
AUB559.86M Technology Information Technology Services 14.75% 19.96% Infotel
INF254.43M Technology Information Technology Services -1.27% -29.01% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Neurones S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Neurones S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.05%, the Debt to Equity ratio from the most recent quarter is 0.10, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for NRO?
- Looking at Neurones S.A's growth, its revenue over the trailing twelve months (TTM) was €857M. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.10%, and quarterly earnings saw a YoY growth of 4.90%.
- How much of NRO stock is held by insiders and institutions?
- Wondering who owns Neurones S.A stock? Company insiders (like executives and directors) hold about 69.64% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 12.05%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.